Publications by authors named "Daniel Macey"

Claim this Profile
A
A Pyrimidine-Based Tubulin Inhibitor Shows Potent Anti-Glioblastoma Activity In Vitro and In Vivo.
Satyanarayana Pochampally, Lawrence M Pfeffer, Gustavo A Miranda-Carboni, Macey Daniel, Jazz I James

Pharmaceuticals (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretherapy prediction of nephrotoxicity after peptide radionuclide receptor therapy (PRRT).
Gerald L Denardo, Daniel J Macey

Cancer Biother Radiopharm· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy.
Ruby Meredith, Sui Shen, Daniel Macey, M B Khazaeli, Delicia Carey

Cancer Biother Radiopharm· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
Sui Shen, Ruby F Meredith, Jun Duan, Daniel J Macey, M B Khazaeli

J Nucl Med· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis